Search the Newsreel

Trinity Biotech plc Sponsored ADR Revenue Breakdown – FWB:TRB0

This article provides a revenue breakdown for Trinity Biotech plc Sponsored ADR (FWB:TRB0), highlighting its financial performance by segment and country. The Americas region was the largest contributor to revenue, generating €27.58 million last year compared to €40.37 million the previous year. The data …

Definitive Healthcare (NASDAQ:DH) Upgraded at Wall Street Zen

Wall Street Zen has upgraded Definitive Healthcare (NASDAQ:DH) from "hold" to "buy," despite a cautious broader analyst view with an average rating of "Reduce" and a target price of $2.47. The stock is trading near its 52-week low at $0.68, with a market capitalization …

RTO|Rentokil Initial PLC|Price:28.370|Chg%:-0.830

This article provides a detailed financial overview of Rentokil Initial PLC (RTO), including its current stock price, market capitalization, P/E ratios, dividend yield, and performance metrics over various periods. It also highlights analyst ratings, with a strong buy consensus from 4 analysts and a …

Affinity Bancshares, Inc. Revenue Breakdown – FWB:5610

Affinity Bancshares, Inc. (FWB:5610) generated its greatest revenue contribution from the United States with 28.15 million EUR last year, a decrease from 30.12 million EUR the previous year. This breakdown is part of the company's financial overview available on TradingView, which also provides statistics, …

Infinite Eagle Acquisition Units (IEAG) Balance Sheet

Affinity Bancshares Inc (AFBI) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides an overview of Affinity Bancshares Inc's (AFBI) dividend history, noting that no dividends have been distributed in the past five years. It also includes current stock information such as market capitalization and P/E ratio. The financial data is delayed by 15 …

Trinity Industries, Inc. (TRN) Q3 2023 Earnings Report - Results, Call & Slides

Trinity Industries, Inc. (TRN) reported its Q3 2023 earnings, beating both EPS and revenue expectations. The company posted an actual EPS of $4.55 against a consensus of $4.52 and actual revenue of $14.38 billion, significantly surpassing the expected $12.30 billion, marking a 65.38% YoY …

Gamco Investors INC. ET AL Has $31.64 Million Stock Holdings in Trinity Industries, Inc. $TRN

Gamco Investors INC. ET AL reduced its stake in Trinity Industries (NYSE:TRN) by 8.3% in Q1 2026, but still holds 983,340 shares valued at approximately $31.64 million. The company reported Q1 EPS of $0.32, exceeding estimates, but revenue missed expectations at $492 million. Trinity …

Definitive Healthcare Corp. Revenue Breakdown – NASDAQ:DH

BIAF vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?

This article compares two cancer diagnostics companies, bioAffinity Technologies (BIAF) and Biodesix (BDSX), to determine which is a better investment. While BIAF focuses on early-stage lung cancer detection with its CyPath Lung test and has strong growth potential, it is in an earlier commercial …

Rentokil Initial plc Stock 12‑Month Price Target Cut to $35.28, Implies 24% Upside

The average 12-month price target for Rentokil Initial plc stock has been slightly reduced from $35.5 to $35.28, according to estimates from 14 analysts. Despite this cut, the new target still implies approximately 24% potential upside based on the Jul. 24 closing price. The …

DH|Definitive Healthcare Corp|Price:0.677|Chg%:-0.008

Definitive Healthcare Corp (DH) is currently trading at $0.683, down 0.42%. Despite healthy fundamentals and high growth potential, its stock price has seen significant declines over the past year. Analysts mostly rate the stock as "Hold" with a target price of $2.20, indicating a …

bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity's Diagnostics for Asthma and COPD | Newswise

bioAffinity Technologies and Pictor®, Inc. have partnered to develop and commercialize bioAffinity's next-generation diagnostic tests for asthma and chronic obstructive pulmonary disease (COPD). This collaboration aims to enhance the throughput and reduce the costs of personalized testing by integrating bioAffinity's flow cytometry expertise with …

bioAffinity Technologies Inc (BIAF) Cash Flow Statement

This article presents the quarterly and annual cash flow statements for bioAffinity Technologies Inc (BIAF), detailing operating, investing, and financing cash flows. It includes financial figures for various quarters and years, along with definitions and FAQs about different types of cash flow and their …

Trinity Capital (TRIN) moves to delist common stock and 7.875% notes from Nasdaq

Trinity Capital Inc. (TRIN) has filed a Form 25 to delist its common stock and two series of 7.875% notes (due March 2029 and September 2029) from The Nasdaq Stock Market LLC. This action signifies the company's intent to remove these securities from Nasdaq …

Trinity Industries Inc (TRN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Trinity Industries Inc (TRN) by business segment for FY2025. The company's primary revenue drivers are Rail products and Leasing and management, accounting for 60.39% and 42.61% of total revenue, respectively. Other segments like Maintenance services, Parts & …

Pest controller Rentokil challenged by slowing US growth - says analyst

Deutsche Bank analysts predict that Rentokil Initial PLC will face challenges in North America due to slowing industry growth in pest control. They expect North American Pest Control organic growth to decline to 3% in Q2 from 4.1% in Q1, influenced by weaker online …

Trinity Biotech PLC|Price:0.299|Chg%:-0.005

Trinity Biotech PLC (TRIB) is a biotechnology company specializing in diabetes management solutions and human diagnostics, including wearable biosensors and diagnostic systems for infectious diseases and chemical parameters. The company's executives include President and CEO John Gillard and founder Ronan O'caoimh. As of Q1 …

Infinity Natural Resources sets Aug. 11 call to discuss Q2 results

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX) and MindWalk Holdings (HYFT)

Analysts have provided optimistic outlooks for healthcare companies Quest Diagnostics (DGX) and MindWalk Holdings (HYFT). Quest Diagnostics received a Buy rating from William Blair with a $231.40 average price target, while MindWalk Holdings also secured a Buy rating from JonesTrading and H.C. Wainwright, with …

TRCI6112193 Bond Profile — Key Metrics

This article provides a bond profile for Trinity Capital Inc.'s 6.75% bond, TRCI6112193, maturing on July 3, 2030. Key metrics include an outstanding amount of $125 million, a face value of $1,000, and a coupon rate of 6.75%. Trinity Capital, Inc. is a specialty …

bioAffinity Technologies, Inc. (BIAF) Stock Price, News, Quote & History

This article provides detailed financial information and an overview of bioAffinity Technologies, Inc. (BIAF). It covers the company's stock performance, key financial metrics, news, and its work in developing non-invasive diagnostic tests for early-stage lung cancer and other lung diseases. The company utilizes flow …

TRN|Trinity Industries Inc|Price:37.050|Chg%:+0.280

Trinity Industries Inc. (TRN) has shown strong fundamentals despite average stock market performance, with high profit growth and dividend payouts. The stock, which is considered fairly valued within its industry, is expected to trend upwards in the medium term, though recent analyst ratings are …

Rentokil Initial slips Thursday, underperforms market

Rentokil Initial PLC (RTO) saw its shares drop by 3.53% to £4.30 on Thursday, underperforming the broader market as the FTSE 100 Index (UKX) also fell. The company's stock is now 15.29% below its 52-week high of £5.07. This decline occurred during an overall …

Trinity Industries (TRN) to Release Earnings on Thursday

Trinity Industries (TRN) is scheduled to release its Q2 2026 earnings before market open on Thursday, July 30th. Analysts anticipate earnings of $1.36 per share and revenue of $498.3 million. The company recently announced a quarterly dividend of $0.31 per share, offering an annualized …

Rentokil Initial (RTO) Expected to Announce Quarterly Earnings on Thursday

Vicinity Centres (ASX:VCX): What Does the Latest Share Price Movement Indicate?

Precision Trading with Affinity Bancshares Inc. (AFBI) Risk Zones

This article analyzes Affinity Bancshares Inc. (AFBI) using AI models, determining a neutral near to mid-term outlook but a long-term positive bias with an exceptional 12.0:1 risk-reward setup. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, along …

Trinity Biotech (NASDAQ: TRIB) plans equity-backed Latch Medical tie-up in CGM-guided drug delivery

Trinity Biotech (NASDAQ: TRIB) has announced a strategic collaboration with Latch Medical Limited, along with an agreed-in-principle equity investment, to develop biosensor-guided precision drug delivery solutions. This partnership aims to combine Trinity Biotech's AI-native CGM+ wearable biosensor platform with Latch Medical's Pharma Latch microneedle-based …

Affinity to be Acquired by Fidelity Bank in Merger Expected to Close Aug. 1, 2026

Affinity Bancshares, Inc. announced a definitive agreement to merge into Fidelity Bank, with the transaction expected to close on August 1, 2026. The merger involves a series of steps where Merger Sub will merge into Affinity, then Affinity into Fidelity Bank, and Affinity Bank …

Trinity Biotech's Wearable Sensors May Guide Drug Delivery

Trinity Biotech and Latch Medical have partnered to combine Trinity Biotech's CGM+ wearable biosensor platform with Latch Medical's Pharma Latch™ intradermal drug delivery technology. This collaboration aims to develop precision therapeutic solutions for conditions like diabetes and obesity by using real-time metabolic data to …

bioAffinity Technologies partners with Pictor to develop high-throughput asthma and COPD diagnostics

bioAffinity Technologies announced a collaboration with Pictor to develop high-throughput diagnostics for asthma and COPD, integrating bioAffinity's flow cytometry sputum platform with Pictor's proteomic analysis. This partnership aims to enhance lab throughput, reduce costs, and offer scalable diagnostic testing. bioAffinity will retain IP rights …

Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology

Trinity Biotech and Latch Medical have formed a strategic collaboration and equity investment to advance biosensor-guided precision drug delivery solutions. The partnership aims to integrate Trinity Biotech's AI-native CGM+ wearable biosensor platform with Latch Medical's intradermal drug delivery technology, Pharma Latch™, to develop next-generation …

Trinity Biotech Plans Mandatory Exchange of 30 ADSs for 1 on July 24

Trinity Biotech (TRIB) announced a mandatory change in its American Depositary Share (ADS) ratio, effective July 24, 2026. The ratio will shift from 1 ADS representing 20 Class A ordinary shares to 1 ADS representing 600 shares, effectively a 1-for-30 reverse ADS split. This …

Trinity Biotech plans 1-for-30 reverse ADS split By Investing.com

Trinity Biotech plc announced a 1-for-30 reverse ADS split, changing its American depositary share ratio to one ADS representing 600 Class A ordinary shares. This move aims to help the company regain compliance with Nasdaq's $1.00 minimum bid price requirement and attract investors who …

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

Trinity Biotech plc (Nasdaq: TRIB) has announced a plan to change its American depositary shares (ADS) ratio from 1 ADS representing 20 Class A ordinary shares to 1 ADS representing 600 Class A ordinary shares. This change, effective July 24, 2026, is designed to …